11.63 0.12(1.04%)06/27/2024
Regenxbio Inc (RGNX)
Regenxbio Inc (RGNX)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
| Headline | Time (ET) | Source |
|---|---|---|
| Regenxbio (RGNX) Soars 6.4%: Is Further Upside Left in the Stock? | 06/25 05:35 | zacks.com |
| 7 Biotech Stocks to Buy on the Dip: June 2024 | 06/24 12:56 | investorplace.com |
| REGENXBIO Announces Expansion of AFFINITY DUCHENNE® Trial to Include a New Cohort of Younger Patients | 06/24 07:05 | prnewswire.com |
| REGENXBIO Announces Successful Pre-BLA Meeting with FDA to Support Accelerated Approval Pathway for RGX-121 for the Treatment of MPS II | 06/18 07:05 | prnewswire.com |
| REGENXBIO Announces Leadership Transition | 06/12 07:05 | prnewswire.com |
| Regenxbio: Transforming Gene Therapy With Innovative AAV Treatments, Strong Buy | 06/10 23:55 | seekingalpha.com |
| REGENXBIO to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference | 06/05 07:05 | prnewswire.com |
| REGENXBIO to Participate in Upcoming Investor Conferences | 05/10 07:05 | prnewswire.com |
| REGENXBIO Inc. (RGNX) Q1 2024 Earnings Call Transcript | 05/08 21:42 | seekingalpha.com |
| Regenxbio (RGNX) Reports Q1 Loss, Lags Revenue Estimates | 05/08 18:40 | zacks.com |